Abstract:Introduction: Pregnancy results in significant changes in drug pharmacokinetics (PK). While previous studies have elucidated the impact of pregnancy-related hormones (PRH) on mRNA or protein expression and activity of major hepatic metabolizing enzymes, their effect on hepatic drug transporters remains largely unexplored. Therefore, we investigated the effect of a cocktail of PRH on the mRNA expression and activity of hepatic transporters. Methods: Plated human hepatocytes (PHH) from 3 premenopausal donors were incubated, in triplicate, for 72 h, with vehicle (DMSO < 0.01%), rifampin (10 μM; positive control) or a cocktail of PRH consisting of estrone, estradiol, estriol, estetrol, progesterone, cortisol, testosterone, oxytocin, and placental growth hormone. The PRH concentrations replicated 0.1×, 1×, or 10× of the plasma concentrations of these hormones observed during each of the three trimesters of pregnancy. After treatment, mRNA expression (quantified by qPCR) of hepatic influx and efflux transporters as well as the activity of influx transporters was quantified (uptake of a selective substrate ± corresponding transporter inhibitor). The data were expressed relative to that in the control (vehicle) group. Significance was evaluated by ANOVA (followed by Dunn's multiple comparisons) or unpaired t-test when the within-lot data were analyzed, or repeated measures ANOVA (followed by Dunn's multiple comparisons) or paired t-test when data from all 3 lots were analyzed (p < 0.05). Results and discussion: In general, a) PRH cocktails significantly induced transporter mRNA expression in the following order OAT2 ≈ NTCP ≈ OCT1 > OATP2B1 and repressed mRNA expression in the following order OATP1B3 > OATP1B1; b) these changes translated into significant induction of OAT2 (T1-T3) and NTCP (T2-T3, in only two lots) activity at the 1× PRH concentration. Compared with the influx transporters, the induction of mRNA expression of efflux transporters was modest, with mRNA expression of MRP2 and BSEP being induced the most. Conclusion: Once these data are verified through in vivo probe drug PK studies in pregnancy, they can be populated into physiologically based pharmacokinetic (PBPK) models to predict, for all trimesters of pregnancy, transporter-mediated clearance of any drug that is a substrate of the affected transporters.

Downregulation of cytochrome P450 expression to mimics Pregnancy induced hypertension

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

CYP4A11/20-HETE induces oxidative stress and inhibits trophoblast proliferation via the PI3K/AKT signaling pathway during preeclampsia

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Alteration in Methylation Level at 11Β-Hydroxysteroid Dehydrogenase Type 2 Gene Promoter in Infants Born to Preeclamptic Women

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Expression of releted genes associated with cell differentiation in placent from hypertension of pregnancy

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

MiRNA‐548c‐5p downregulates inflammatory response in preeclampsia via targeting PTPRO

Relationship Between 11Β-Hydroxysteroid Dehydrogenase 2 Gene Expression in Placenta of Pregnancy Induced Hypertension Mother and Newborn′s Birth Weight

Downregulation of CD151 induces oxidative stress and apoptosis in trophoblast cells via inhibiting ERK/Nrf2 signaling pathway in preeclampsia

MicroRNA-195-5p Attenuates Pregnancy-Induced Hypertension by Inhibiting Oxidative Stress via OTX1/MAPK Signaling Pathway

The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes

Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling

Therapeutic potential of Omega-3 polyunsaturated fatty acids on the immune function of patients with hypertensive disorder complicating pregnancy and preeclampsia

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies

The Association between Gut Microbiome and Pregnancy-Induced Hypertension: A Nested Case-Control Study

Enos and Enos Mrna Expression in Placental Villus and Changes in Plasma Endothelin-1, Nitric Oxide, Calcium, Magnesium, and Relationship of Calcium and Magnesium in Red Blood Cell in Patients with Pregnancy-induced Hypertension